Acetazolamide
استازولامید
👁️ Sensory OrgansCarbonic anhydrase inhibitor
Market / country: 🇺🇸 USA
Diamox (US)
🧮 Dose calculator
Open-angle glaucoma / ocular hypertension · Regimen source: FDA Acetazolamide · Dosage and Administration
- • Divide doses above 250 mg; more than 1 g/day adds no effect. Secondary and acute angle-closure glaucoma per label. FDA Acetazolamide · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to acetazolamide or sulfonamides; low sodium or potassium; marked renal or hepatic disease; adrenal failure; hyperchloraemic acidosis. FDA Acetazolamide · Contraindications
Formulations
- 125 mg tablet (scored) — tablet 🇺🇸 USA FDA Acetazolamide · How Supplied
- 250 mg tablet (quarter-scored) — tablet 🇺🇸 USA FDA Acetazolamide · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Acetazolamide · Pregnancy: Teratogenic effects
“Acetazolamide, administered orally or parenterally, has been shown to be teratogenic (defects of the limbs) in mice, rats, hamsters, and rabbits.”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Acetazolamide · Nursing Mothers
“Because of the potential for serious adverse reactions in nursing infants from acetazolamide, a decision should be made whether to discontinue nursing or to discontinue the drug taking into account the importance of the drug to the mother.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Acetazolamide · Pediatric Use
“The safety and effectiveness of acetazolamide in pediatric patients has not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Acetazolamide · Geriatric Use
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA211151
- DailyMed (FDA label)FDA Acetazolamide
- MedlinePlus (NIH)Acetazolamide
- WHO ATC/DDDS01EC01
- Darooyab (Iran)Acetazolamide
🇮🇷 Registered in Iran Darooyab · G-1508/Acetazolamide
Dosage forms with Iranian generic codes, per Darooyab.
- 00011 · ACETAZOLAMIDE 250MG TAB · قرص آستازولامید ۲۵۰ میلیگرم
- 00012 · ACETAZOLAMIDE 500MG INJ · فرآورده تزریقی آستازولامید ۵۰۰ میلیگرم
- 18326 · ACETAZOMID 500MG ING. · آستازومید ۵۰۰ میلیگرم اینگ .
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Acetazolamide · How SuppliedFDA Acetazolamide · Dosage and AdministrationFDA Acetazolamide · Dosage and Administration — Acute Mountain SicknessFDA Acetazolamide · ContraindicationsFDA Acetazolamide · SPL approval / marketing categoryFDA Acetazolamide · Pregnancy: Teratogenic effectsFDA Acetazolamide · Nursing MothersFDA Acetazolamide · Pediatric UseFDA Acetazolamide · Geriatric Use
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1508/Acetazolamide
- Clinical review⚠ Unverified